Castle Biosciences, Inc. - Common stock - Çeyreklik Finansal İstatistikler (NASDAQ:CSTL) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit 24.36 M-6.04 M20.82 M22.63 M26.93 M-22.13 M 48.25 M Yatırım faaliyetlerinden elde edilen nakit 5.77 M-22.43 M-28.38 M-18.39 M8.83 M-25.8 M -63.74 M Finansman faaliyetlerinden elde edilen nakit -5.38 M-1.55 M101 K-919 K-4.59 M-5.03 M -10.44 M Serbest nakit akışı 24.36 M-6.04 M11.56 M7.8 M19.75 M-34.58 M 4.52 M

Haberler

BTIG, yüksek maliyetler nedeniyle Castle Biosciences hisse hedefini düşürdü

Castle Biosciences 1Ç 2026: Gelir beklentiyi aştı, rehberlik yükseltildi

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know